Novartis a well know pharmaceuticals company has announced and called for the halt on distribution on the Generic version of Zantac a very common heartburn medicine.

According to the Novartis the announcment of halt is precautionary.
In the previous week it was announced by the FDA that it detected containment of cancer causing agents in the medicationi.

According to the company official statement they have stopped the worldwide distribution while this is investigated further by the regulatory health authorities of USA and Europe.

Moreover this is important to note that halt on the distribution doesn’t mean that existing stock in the stores has been recalled instead this means that existing stock still could be sold.